Titre : Régions 5' non traduites

Régions 5' non traduites : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Collection
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Régions 5' non traduites : Questions médicales les plus fréquentes", "headline": "Régions 5' non traduites : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Régions 5' non traduites : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-19", "dateModified": "2025-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Régions 5' non traduites" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Régions non traduites", "url": "https://questionsmedicales.fr/mesh/D020506", "about": { "@type": "MedicalCondition", "name": "Régions non traduites", "code": { "@type": "MedicalCode", "code": "D020506", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.024.340.137.910" } } }, "about": { "@type": "MedicalCondition", "name": "Régions 5' non traduites", "alternateName": "5' Untranslated Regions", "code": { "@type": "MedicalCode", "code": "D020121", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nicola Whiffin", "url": "https://questionsmedicales.fr/author/Nicola%20Whiffin", "affiliation": { "@type": "Organization", "name": "National Heart and Lung Institute and MRC London Institute of Medical Science, Imperial College London, London W12 0NN, UK." } }, { "@type": "Person", "name": "Olga A Nikolaitchik", "url": "https://questionsmedicales.fr/author/Olga%20A%20Nikolaitchik", "affiliation": { "@type": "Organization", "name": "Viral Recombination Section, HIV Dynamics and Replication Program, National Cancer Institute, Frederick, Maryland, USA." } }, { "@type": "Person", "name": "Vinay K Pathak", "url": "https://questionsmedicales.fr/author/Vinay%20K%20Pathak", "affiliation": { "@type": "Organization", "name": "Viral Mutation Section, HIV Dynamics and Replication Program, National Cancer Institute, Frederick, Maryland, USA." } }, { "@type": "Person", "name": "Wei-Shau Hu", "url": "https://questionsmedicales.fr/author/Wei-Shau%20Hu", "affiliation": { "@type": "Organization", "name": "Viral Recombination Section, HIV Dynamics and Replication Program, National Cancer Institute, Frederick, Maryland, USA." } }, { "@type": "Person", "name": "William E Tapprich", "url": "https://questionsmedicales.fr/author/William%20E%20Tapprich", "affiliation": { "@type": "Organization", "name": "Biology Department, University of Nebraska at Omaha, Omaha, Nebraska, USA wtapprich@unomaha.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Data collection on rare bone and mineral conditions in Europe: The landscape of registries and databases.", "datePublished": "2023-10-30", "url": "https://questionsmedicales.fr/article/38832910", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejmg.2023.104868" } }, { "@type": "ScholarlyArticle", "name": "Ethical Considerations for Artificial Intelligence in Medical Imaging: Data Collection, Development, and Evaluation.", "datePublished": "2023-12-01", "url": "https://questionsmedicales.fr/article/37827839", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2967/jnumed.123.266080" } }, { "@type": "ScholarlyArticle", "name": "Exploring the perspectives of selectors and collecters of trial outcome data: an international qualitative study.", "datePublished": "2023-10-11", "url": "https://questionsmedicales.fr/article/37821867", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12874-023-02054-9" } }, { "@type": "ScholarlyArticle", "name": "Do privacy assurances work? a study of truthfulness in healthcare history data collection.", "datePublished": "2022-11-09", "url": "https://questionsmedicales.fr/article/36350919", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0276442" } }, { "@type": "ScholarlyArticle", "name": "Single-Particle Cryo-EM Data Collection with Stage Tilt using Leginon.", "datePublished": "2022-07-01", "url": "https://questionsmedicales.fr/article/35848829", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3791/64136" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Génome", "item": "https://questionsmedicales.fr/mesh/D016678" }, { "@type": "ListItem", "position": 5, "name": "Composants de génome", "item": "https://questionsmedicales.fr/mesh/D040481" }, { "@type": "ListItem", "position": 6, "name": "Gènes", "item": "https://questionsmedicales.fr/mesh/D005796" }, { "@type": "ListItem", "position": 7, "name": "Composants de gène", "item": "https://questionsmedicales.fr/mesh/D040461" }, { "@type": "ListItem", "position": 8, "name": "Régions non traduites", "item": "https://questionsmedicales.fr/mesh/D020506" }, { "@type": "ListItem", "position": 9, "name": "Régions 5' non traduites", "item": "https://questionsmedicales.fr/mesh/D020121" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Régions 5' non traduites - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Régions 5' non traduites", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Régions 5' non traduites", "description": "Comment identifier les 5' UTR dans un gène ?\nQuels tests sont utilisés pour étudier les 5' UTR ?\nLes 5' UTR sont-elles visibles sur des électrophorèses ?\nPeut-on détecter des mutations dans les 5' UTR ?\nQuel rôle jouent les 5' UTR dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D020121?mesh_terms=Data+Collection&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Régions 5' non traduites", "description": "Les 5' UTR sont-elles liées à des symptômes cliniques ?\nQuels symptômes peuvent indiquer un problème avec les 5' UTR ?\nLes 5' UTR affectent-elles la réponse aux traitements ?\nPeut-on relier les 5' UTR à des syndromes spécifiques ?\nLes 5' UTR sont-elles impliquées dans des cancers ?", "url": "https://questionsmedicales.fr/mesh/D020121?mesh_terms=Data+Collection&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Régions 5' non traduites", "description": "Peut-on prévenir les anomalies des 5' UTR ?\nY a-t-il des facteurs environnementaux affectant les 5' UTR ?\nComment le mode de vie influence-t-il les 5' UTR ?\nLes dépistages génétiques aident-ils à prévenir les problèmes liés aux 5' UTR ?\nLes vaccinations influencent-elles les 5' UTR ?", "url": "https://questionsmedicales.fr/mesh/D020121?mesh_terms=Data+Collection&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Régions 5' non traduites", "description": "Comment les traitements ciblent-ils les 5' UTR ?\nLes médicaments peuvent-ils interagir avec les 5' UTR ?\nY a-t-il des traitements pour corriger les anomalies des 5' UTR ?\nLes traitements ciblant les 5' UTR sont-ils efficaces ?\nLes 5' UTR influencent-elles la résistance aux traitements ?", "url": "https://questionsmedicales.fr/mesh/D020121?mesh_terms=Data+Collection&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Régions 5' non traduites", "description": "Quelles complications peuvent survenir avec des anomalies des 5' UTR ?\nLes anomalies des 5' UTR peuvent-elles entraîner des complications héréditaires ?\nComment les 5' UTR affectent-elles le pronostic des maladies ?\nLes complications liées aux 5' UTR sont-elles réversibles ?\nLes 5' UTR sont-elles impliquées dans des complications post-thérapeutiques ?", "url": "https://questionsmedicales.fr/mesh/D020121?mesh_terms=Data+Collection&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Régions 5' non traduites", "description": "Quels sont les facteurs de risque pour les anomalies des 5' UTR ?\nL'âge est-il un facteur de risque pour les anomalies des 5' UTR ?\nLes habitudes alimentaires influencent-elles les 5' UTR ?\nLe stress peut-il affecter les 5' UTR ?\nLes infections virales sont-elles un facteur de risque pour les anomalies des 5' UTR ?", "url": "https://questionsmedicales.fr/mesh/D020121?mesh_terms=Data+Collection&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les 5' UTR dans un gène ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les 5' UTR peuvent être identifiées par séquençage d'ARN et analyse bioinformatique." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les 5' UTR ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent le RT-PCR et les analyses de l'expression génique." } }, { "@type": "Question", "name": "Les 5' UTR sont-elles visibles sur des électrophorèses ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être visualisées sur des gels d'électrophorèse après amplification." } }, { "@type": "Question", "name": "Peut-on détecter des mutations dans les 5' UTR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations peuvent être détectées par séquençage ciblé des régions 5' UTR." } }, { "@type": "Question", "name": "Quel rôle jouent les 5' UTR dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles influencent la régulation de l'expression génique, affectant le diagnostic de maladies." } }, { "@type": "Question", "name": "Les 5' UTR sont-elles liées à des symptômes cliniques ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans les 5' UTR peuvent entraîner des symptômes variés selon le gène affecté." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec les 5' UTR ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes peuvent inclure des troubles métaboliques ou des maladies neurodégénératives." } }, { "@type": "Question", "name": "Les 5' UTR affectent-elles la réponse aux traitements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations dans les 5' UTR peuvent influencer l'efficacité des traitements médicamenteux." } }, { "@type": "Question", "name": "Peut-on relier les 5' UTR à des syndromes spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mutations dans les 5' UTR sont associées à des syndromes génétiques spécifiques." } }, { "@type": "Question", "name": "Les 5' UTR sont-elles impliquées dans des cancers ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des altérations dans les 5' UTR peuvent contribuer à la carcinogenèse dans certains cancers." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des 5' UTR ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par des conseils génétiques et un suivi médical pour les familles à risque." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux affectant les 5' UTR ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes liés aux 5' UTR." } }, { "@type": "Question", "name": "Comment le mode de vie influence-t-il les 5' UTR ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut réduire le risque d'anomalies génétiques, y compris celles des 5' UTR." } }, { "@type": "Question", "name": "Les dépistages génétiques aident-ils à prévenir les problèmes liés aux 5' UTR ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage génétique peut identifier les risques et permettre une intervention précoce." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles les 5' UTR ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations n'affectent pas directement les 5' UTR, mais protègent contre certaines maladies." } }, { "@type": "Question", "name": "Comment les traitements ciblent-ils les 5' UTR ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des oligonucléotides peuvent cibler les 5' UTR pour moduler l'expression." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils interagir avec les 5' UTR ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent moduler l'activité des 5' UTR, influençant la traduction." } }, { "@type": "Question", "name": "Y a-t-il des traitements pour corriger les anomalies des 5' UTR ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des approches de thérapie génique sont en développement pour corriger ces anomalies." } }, { "@type": "Question", "name": "Les traitements ciblant les 5' UTR sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité dépend du type de mutation et du contexte biologique de la maladie." } }, { "@type": "Question", "name": "Les 5' UTR influencent-elles la résistance aux traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations dans les 5' UTR peuvent être liées à la résistance aux traitements anticancéreux." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des anomalies des 5' UTR ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des maladies métaboliques, des cancers ou des troubles neurologiques." } }, { "@type": "Question", "name": "Les anomalies des 5' UTR peuvent-elles entraîner des complications héréditaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines anomalies peuvent être transmises et causer des complications héréditaires." } }, { "@type": "Question", "name": "Comment les 5' UTR affectent-elles le pronostic des maladies ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les variations dans les 5' UTR peuvent influencer le pronostic et la réponse au traitement." } }, { "@type": "Question", "name": "Les complications liées aux 5' UTR sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles selon la maladie." } }, { "@type": "Question", "name": "Les 5' UTR sont-elles impliquées dans des complications post-thérapeutiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des modifications dans les 5' UTR peuvent contribuer à des complications après traitement." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies des 5' UTR ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des expositions environnementales et des mutations." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour les anomalies des 5' UTR ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé peut augmenter le risque de mutations dans les 5' UTR et d'autres gènes." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les 5' UTR ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines habitudes alimentaires peuvent affecter l'expression des gènes, y compris les 5' UTR." } }, { "@type": "Question", "name": "Le stress peut-il affecter les 5' UTR ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut influencer l'expression génique et potentiellement affecter les 5' UTR." } }, { "@type": "Question", "name": "Les infections virales sont-elles un facteur de risque pour les anomalies des 5' UTR ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales peuvent induire des modifications dans les 5' UTR, augmentant les risques." } } ] } ] }

Sources (10000 au total)

Data collection on rare bone and mineral conditions in Europe: The landscape of registries and databases.

knowledge on the natural history of rare diseases is necessary to improve outcomes. Disease registries may play a key role in covering these unmet needs in the rare bone and mineral community.... to map existing bone and mineral conditions registries in Europe and their characteristics.... online survey about the use of registries/databases and their characteristics. This survey was disseminated among members of the European Reference Network on Rare Bone Diseases (ERN BOND) and non-ERN... sixty-three responses from health care providers (HCPs) and 10 responses from patient groups (PGs) were collected. The response rate for ERN BOND members was 55%. Of 63 HCPs, 37 declared using a regis... There is a need for developing a common high-quality platform for registering rare bone and mineral conditions....

Exploring the perspectives of selectors and collecters of trial outcome data: an international qualitative study.

Selecting and collecting data to support appropriate primary and secondary outcomes is a critical step in designing trials that can change clinical practice. In this study, we aimed to investigate who... One-with-one semi-structured interviews, supported by a topic guide to ensure coverage of key content. The Framework approach was used for thematic analysis of data, and themes were linked through con... We identified three descriptive themes encompassing the process of primary and secondary outcome selection, collection, and the publication of outcome data. Within these themes, participants raised is... People involved in the design and conduct of trials fail to connect decisions around outcome selection with data collection workload. Publication of outcome data and effective dissemination of trial r...

Use of the BACtrack Skyn alcohol biosensor: Practical applications for data collection and analysis.

Alcohol biosensors, including the BACtrack Skyn, provide an objective and passive method of continuously assessing alcohol consumption in the natural environment. Despite the many strengths of the Sky... Procedures from several laboratory and field-based pilot studies are presented to demonstrate practical recommendations for Skyn use. Data from a pilot study including a 7-day ecological momentary ass... To address challenges in the collection and processing of data from the BACtrack Skyn alcohol biosensor, researchers should identify goals in advance of data collection to anticipate the processing ne...

Managing the elephant in the room: responding to COVID-19's impact on data collection.

The global COVID-19 pandemic has affected data collection for many researchers, in particular research that involves face-to-face interviews.... To share learning about the challenges encountered when face-to-face interviews could not continue as planned in a study and how to adapt data collection so that it can continue despite severe disrupt... This article examines the considerations and actions taken by the authors to ensure the continuity of data collection. The research aimed to use narrative inquiry to understand the experiences of sign... Adapting data collection is valuable in ensuring the continuity of research. Careful consideration and planning are required to ensure the research remains robust and ethically sound.... Adapting data collection methods can allow for greater flexibility when participants cannot attend face-to-face interviews....

Dealing With Immunoglobulin Shortages: A Rationalization Plan From Evidence-Based and Data Collection.

The demand and consumption of immunoglobulins (IgGs) are growing, and there are many difficulties in obtaining supplies. The aim of the study was to analyze the evolution of IgG consumption and cost o... We performed a retrospective longitudinal study including patients of all public health systems in Catalonia. First, we analyzed data on consumption and cost of IgGs during a period between 1 January,... Overall, in terms of population, the consumption of IgGs (g/1,000 inhabitants) increased from 40.4 in 2010 to 94.6 in 2021. The mean cost per patient increased from €10,930 in 2010 to €15,595 in 2021.... The annual consumption and cost of IgGs have grown steadily over the last decade in our regional public health system. After implementing a set of regional measures, the annual consumption of IgGs per...